Davis-based Expanesthetics raises nearly $3 million

The company licenses technology developed by a UC Davis researcher to analyze compounds and identify alternatives to common anesthetics and analgesics.

Source: bizjournals.com Health Care:Biotechnology headlines - September 26, 2017 Category: Biotechnology Authors: Scott Rodd Source Type: news